Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, provides guidance

February 25, 2026 4:40 PM EST

Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $64.45 million versus the consensus estimate of $62.98 million.

GUIDANCE:

Lemaitre Vascular sees Q1 2026 revenue of $65.6-67.6 million, versus the consensus of $65.85 million.

Lemaitre Vascular sees FY2026 revenue of $276-284 million, versus the consensus of $270.5 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK